A Phase I/II Clinical Trial Assessing Safety and Efficacy of Estetrol (E4) in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Estetrol (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Pantarhei Oncology
- 29 Mar 2018 Planned End Date changed from 1 May 2018 to 1 Oct 2018.
- 29 Mar 2018 Planned primary completion date changed from 1 May 2018 to 1 Oct 2018.
- 01 Jun 2017 Status changed from not yet recruiting to recruiting.